The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
£31k delayed buy from earlier today has just been published....following on from a number of large buys yesterday shows confidence . It wasn't my but but I did top up with smaller amounts earlier today....I think WBI is coming in under radar now.
Indy ,
thanks for the update on your wife's athletic activities. She sounds like a super athlete although I'm now experiencing distressing flashbacks and now have visions of East German shot putters from the 1970's competing at those type of challenging sporting events ! I hope she is not taking performance enhancing drugs . If Avacta bring out a test to detect then she could be joining her friends in HMP Belmarsh soon......
https://www.theatlantic.com/health/archive/2020/08/how-to-test-every-american-for-covid-19-every-day/615217/
Informative and lengthy article published in The Atlantic.com ( August 2020).
(It should be noted that Avacta is targeting the "most infectious" persons with the development of its rapid Covid 19 antigen test . The company has used that terminology in recent RNS releases )
From the article,
Professor Mina (Harvard University)
"There is good evidence to infer that a high viral load, which is what antigen tests detect, is correlated with infectiousness. The more virus in your body, the more contagious you are........
In that light, paper antigen tests aren’t SARS-CoV-2 tests at all, not like PCR tests are. They are rapid, cheap COVID-19 contagiousness tests. That shift in thinking, Mina argues, should undergird a shift in our national strategy.....
Mina wants to coat the country in COVID-19 contagiousness tests. To understand the scale of his vision, start with the closest American analogue, the ubiquitous, paper-based, inexpensive at-home pregnancy test. Americans use 20 million of those each year. "
An interesting comment in the article from the CEO of "e25 bio" Bobby Brooke Herrera .This is the start up company which has only 12 employees in Cambridge USA and has now abandoned development of its rapid antigen Covid 19 saliva test . It appears e25 bio struggled to reach the minimum FDA sensitivity requirement of 80% for rapid antigen tests. Shame they don't have affimers to use !
“The FDA, early on in the outbreak, said we had to follow a rubric of 80 percent sensitivity compared to PCR. How they got that number, I’m uncertain, but my best guess is it came from influenza epidemics in the past,” Herrera said.
This requirement has made antigen tests worse, Herrera argues, because it causes manufacturers to prioritize sensitivity at the cost of speed or convenience. It’s why other antigen tests use readers, or centrifuges, or look for nucleocapsid, he contends. By slightly weakening those guidelines, to 60 or 70 percent sensitivity, the FDA could let cheaper at-home tests come to market. The models that e25 uses show that even an at-home test that caught 50 percent of positives and 90 percent of negatives could detect outbreaks and reduce COVID-19 transmission."
RMfatGB,
thank you for your insightful post. I note you previously posted that you worked at Avacta for five years between 2007-2012. It's good to have another BB contributor with your knowledge of the company and experience in the field assisting fellow investors.
Umar Kamani's tweet included a globe meme.......
Muck165,
that's a highly significant and relevant publication (dated 17th August). It was also posted last night on another board. I've started to read through it.
-It's dated 17th August so ties in well with the media push made by Matt Han**** yesterday about mass testing being the way forward
-the publication is signed by Tony Bair, Jeremy Hunt & William Hague.
-In summary the publication calls on the Uk govt to adopt mass rapid testing of the majority of the population on a repeat basis asap. Heavily weighted towards antigen testing to identify asymptomatic persons rather than the previous uk govt policy of only testing persons with covid 19 symptoms !
-Mass repeat testing is the way to avoid a second wave and will support the uk economy to become fully functional again
- The publication is fully supportive of the UK diagnostic industry
thanks gmcc . I admit I too was baffled by the info ( I wish I really was a boffin lol)
https://www.adeptrix.com/technology
Adeptrix , Avacta's partner in the development of a high throughput COVID 19 antigen test using Adeptrix's proprietary BAMS platform has quite a lot of info on its website about the technology. I'm pretty sure this is recently updated on Adeptrix's website . Looking forward to a decent RNS soon.
saw it on twitter ! and it's now doing the rounds ..........
https://www.gov.uk/government/news/new-saliva-test-for-coronavirus-piloted-in-southampton
"In addition to the new application of using saliva from Optigene being piloted in Southampton, we are currently exploring the potential of other no-swab saliva-based coronavirus tests with companies, including Chronomics, Avacta, MAP Science and Oxford Nanoimaging (ONI). We are also working with a number of suppliers, including DNA Genotek, International Scientific Supplies Ltd, Isohelix and other leading manufacturers, to develop bespoke saliva collection kits and scale up manufacturing for products that can be used with existing PCR tests."
The Times article this morning regarding the Southampton trial.It's behind a paywall . However, its clear UK plc sees value in saliva testing to catch asymptomatic cases to manage local flare-ups of covid-19.
"The trial, which will be validated by comparing the results with traditional swab tests, will eventually include 40,000 people and provide the first concrete evidence of whether mass testing can be effective at scale in reducing infection rates. If successful, officials say, it could eventually replace throat and nasal swab tests that are difficult and unpleasant to take and are believed to return false negative results in up to 30 per cent of cases.
https://www.thetimes.co.uk/article/weekly-saliva-checks-are-first-step-towards-national-coronavirus-testing-m78tt3vqx
"It could also allow the government to introduce mass surveillance testing to catch asymptomatic cases, which could represent 70 per cent of all infections, figures from the Office for National Statistics suggest. This could be used to deal with local “flare-ups” without the need for extensive lockdowns."
100% correct Oxygen . No share tipster or anyone else can predict the short, medium or long term future share price of Avacta unless they possess a crystal ball . The share tipsters have no idea what specific news Avacta will release to the market to boost it's market cap. Companies with the best potential tend to divide opinion a lot more .That is even more the case with disruptive companies. Take Tesla as an example . There's a company with a loyal following of fans and shareholders but also it has been heavily shorted . Judging from it's huge market cap I would say that the bulls are winning overall.
Yes, David Wilson from Avacta very positive summing up .”very confident”
I’ve never read a bulletin board with so many vague derampers . I accept that some traders will not be as bullish as most investors regarding the current share price but the general quality of deramping posts is poor . Please do better ladies and gents lol . Good luck to all genuine Avacta investors . Looking strong for continued growth .
Tragically , the Covid-19 situation is India is already out of control . The government has eased lock downs hoping to save the economy. But with a population of 1.3 billion the country is nowhere near its peak in terms of infections. Testing and medical care is poor. The country is believed to be nowhere near the peak of infections . Nobody can state accurately when infections will peak .With no effective lock down systems how can it ever stop infections ravaging the whole country?
"Delhi’s deputy chief minister, Manish Sisodia, has said the capital will have more than 500,000 Covid-19 cases by July and will need to increase the number of beds from 9,000 to 80,000 to meet demand. “For Delhi, this is a big problem if cases continue to rise,” Sisodia said."
https://www.theguardian.com/world/2020/jun/12/india-coronavirus-agony-i-did-everything-to-save-my-wife-and-baby
Winnifrith invariably takes a contrarian view by writing articles on his website , ************* , on popular stocks such as Avacta which have seen a big increase in share price (companies which are popular with investors ).He courts controversy by going against the grain of popular views and this naturally results in more interest in the articles he publishes on ************* out of morbid curiousity ! . The fact that we have a thread running on this board talking about him is evidence that his approach increases interest in his website .Plus of course to read all his articles on ************* it’s approximately £6 a month! Hence he has created a clever business model .
https://twitter.com/dswilsondx/status/1270684484564852743?s=21
Just tweeted by David Wilson #AVCT “looking forward to an interesting discussion “
"For me the first sign or rather a reminder of what AIM is, was the raise made when we were told there was to be none...simples. Most of you now wish to overlook that fact, which is fine."
Bladey , Avacta CEO did not not state there would be no fund raise . I recall the CEO stating in the webinar that Avacta are "fully funded". The CEO did not state in an RNS or Webinar there would be no fund raise. As MilkMONSTA has stated the recent fund raise is a smart strategic move because it strengthens even more the companies financial position and no longer leaves them vulnerable to a weak takeover bid IMHO.
It’s great to see the company being highlighted in a mainstream paper . Avacta is still “ under the radar” in terms of its full potential . Some folks argue we are in a Covid 19 investment bubble .That is certainly the case for a number of companies trying to cash in on the present climate . However , Avacta is a well established company with an excellent CEO plus quality directors/staff which offers investors and traders alike the opportunity to make life changing amounts of money plus the chance to support a company advancing medical science .
https://www.thisismoney.co.uk/money/investing/article-8362013/Mole-Valley-fund-house-launches-Yorkshire-T20-portfolio.html
One of the firms the T20 is investing in is biotech Avacta, which is working to develop an instant testing kit for Covid-19, in addition to a new class of cancer drugs aimed at patients who don't respond to existing therapies.
Avacta chief executive Alastair Smith says: 'I'm a Yorkshireman myself and many of our employees based at our Wetherby lab and head office are local, and it's great to have a showcase like this for the innovation and entrepreneurship going on in Yorkshire.'